miglustat and its Impurities
Miglustat is used to treat adults with mild-to-moderate type I Gaucher disease for whom enzyme replacement therapy is unsuitable. It is marketed under the trade name Zavesca. Reference standards of Miglustat API,and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.


(2R,3R,4R,5S)-3,4,5-Tris(benzyloxy)-2-((benzyloxy)methyl)-1-butylpiperidine Hydrochloride
(2R,3R,4R,5S)-3,4,5-Tris(benzyloxy)-2-((benzyloxy)methyl)-1-butylpiperidine Hydrochloride
Catalogue No.:PA 13 2131001
CAS :
1938122-78-1
Molecular Formula : C38H46ClNO4
Molecular Weight : 616.24


1-((3aR,5R,6S,6aR)-6-Hydroxy-2,2-dimethyltetrahydrofuro[2,3-d][1,3]dioxol-5-yl)ethane-1,2-diol
1-((3aR,5R,6S,6aR)-6-Hydroxy-2,2-dimethyltetrahydrofuro[2,3-d][1,3]dioxol-5-yl)ethane-1,2-diol
Catalogue No.:PA 13 2131011
CAS :
253328-56-2
Molecular Formula : C9H16O6
Molecular Weight : 220.22